Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin Launches Bioequivalent of Xigduo XR in US Across Multiple Strengths

Lupin wins USFDA nod for Risperidone for extended-release injectable suspension for schizophrenia

Written By Ruchika Sharma3 Sept 2025 2:30 PM IST

This is Lupin's first product using proprietary Nanomi B.V.'s technology and has a 180-day CGT exclusivity.

Unichem Pharma USA recalls one lot of Cyclobenzaprine Hydrochloride Tablets 10 mg over mislabeling

Written By Ruchika Sharma3 Sept 2025 1:33 PM IST

East Brunswick: Unichem Pharmaceuticals (USA), Inc. is voluntarily recalling one lot of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, to...

Novartis to Acquire Excellergy in USD 2 Billion Deal to Boost Food Allergy Pipeline

Novartis Leqvio shows statistically significant, clinically meaningful early LDL-C goal achievement with less muscle pain

Written By Ruchika Sharma2 Sept 2025 12:25 PM IST

Basel: Novartis has announced positive results from V-DIFFERENCE, a Phase IV study evaluating Leqvio (inclisiran) compared to placebo, both...

Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 crore

Royalty Pharma to buy royalty interest in Amgen Imdelltra for up to USD 950 million

Written By Ruchika Sharma2 Sept 2025 11:45 AM IST

New York: Royalty Pharma plc has announced that the company has acquired a royalty interest in Amgen's Imdelltra, a first-in-class DLL3 targeting...

Boehringer Ingelheim to Set Up AI-Driven Drug Discovery Centre in London

Boehringer Ingelheim Hernexeos approved in China for previously treated patients with HER2-mutant advanced NSCLC

Written By Ruchika Sharma2 Sept 2025 10:50 AM IST

Boehringer Ingelheim has received approval for HERNEXEOS (zongertinib tablets) from China's National Medical Products Administration (NMPA) as...

Factory manufacturing banned oxytocin injections busted in Lucknow, 4 arrested

Written By Ruchika Sharma1 Sept 2025 2:49 PM IST

Lucknow: The Food Safety and Drug Administration (FSDA), in collaboration with the Special Task Force (STF) has seized 230 liters of fake...

AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus

AstraZeneca eyes year-end filing for BP drug Baxdrostat

Written By Ruchika Sharma1 Sept 2025 12:26 PM IST

Bengaluru: AstraZeneca plans to seek regulatory approval for its experimental blood pressure drug, baxdrostat, by the end of the year, a senior...

Abbott India Hit With Rs 2.40 Cr GST Penalty Over Alleged ITC Disallowance, Plans Appeal

Abbott Dissolving Stent receives CE Mark in Europe for peripheral artery disease

Written By Ruchika Sharma31 Aug 2025 12:30 PM IST

Abbott Park, Ill: Abbott has announced it has received CE Mark in Europe for the Esprit BTK Everolimus Eluting Resorbable Scaffold System (Esprit...

Cipla, Hetero win bid to supply widely prescribed diabetes drug in China

Piramal Pharma Solutions, George Medicines develop new hypertension drug Widaplik

Written By Ruchika Sharma31 Aug 2025 11:30 AM IST

Mumbai: George Medicines, a late-stage biopharma company, in partnership with Piramal Pharma Solutions (PPS), a global Contract Development and...

BioArctic inks pact with Novartis regarding treatment combining BrainTransporter technology with undisclosed target in neurodegeneration

Written By Ruchika Sharma31 Aug 2025 2:30 AM IST

Stockholm: BioArctic AB (publ) has announced that the company has entered into an option, collaboration and license agreement with Novartis...

Biogen, Eisai get USFDA nod for Leqembi Iqlik Subcutaneous Injection for maintenance dosing for early Alzheimer's Disease

Written By Ruchika Sharma30 Aug 2025 4:02 PM IST

Tokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

Aurobindo Pharma arm Telangana facility gets 5 USFDA observations

Written By Ruchika Sharma30 Aug 2025 1:30 PM IST

Hyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (US FDA) has concluded an inspection with five...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok